Monopar Therapeutics Inc. · NASDAQ:MNPR
Robinson Chandler reported a 7.50% stake in Monopar Therapeutics Inc. (Schedule 13D/A)
Event Sep 24, 2025 · Filed Sep 24, 2025
Robinson Chandler reported a 7.50% stake in Monopar Therapeutics Inc., 506,199 shares, with active intent on Sep 24, 2025. Filed Sep 24, 2025 (Schedule 13D/A).
- Stake
- 7.50%
- Shares
- 506,199
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Tactic Pharma LLC | 4.10% | 272,026 |
| Mazar Andrew Paul | 4.10% | 272,026 |
| Robinson Chandler | 7.50% | 506,199 |
| O'Halloran Thomas V. | 4.10% | 272,026 |
| Brown Michael J | 5.10% | 338,067 |
Source
Related
- Monopar Therapeutics Inc.
- Robinson Chandler
- Monopar Therapeutics Inc. shareholders
- Schedule 13D/A · Robinson Chandler · Jan 30, 2026
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026